WilmerHale Advises Biogen in Acquisition of RayThera
June 22, 2026
June 22, 2026
WASHINGTON, June 22 [Category: BizLaw/Legal] -- WilmerHale, a law firm, posted the following news:
* * *
WilmerHale Advises Biogen in Acquisition of RayThera
*
On June 17, 2026, Biogen Inc. (Nasdaq: BIIB) announced that it has entered into a definitive agreement to acquire RayThera Inc., a private biotechnology company focused on the discovery and development of small molecule therapies in immunology. Under the agreement, Biogen has agreed to a . . .
* * *
WilmerHale Advises Biogen in Acquisition of RayThera
*
On June 17, 2026, Biogen Inc. (Nasdaq: BIIB) announced that it has entered into a definitive agreement to acquire RayThera Inc., a private biotechnology company focused on the discovery and development of small molecule therapies in immunology. Under the agreement, Biogen has agreed to a . . .